These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 20556313

  • 41. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2010 Mar 12; 59(9):253-7. PubMed ID: 20224541
    [Abstract] [Full Text] [Related]

  • 42. Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).
    Oosterhuis-Kafeja F, Beutels P, Van Damme P.
    Vaccine; 2007 Mar 08; 25(12):2194-212. PubMed ID: 17267077
    [Abstract] [Full Text] [Related]

  • 43. [Pneumococcal vaccination in obstructive lung diseases -- what can we expect?].
    Rose M, Lode H, de Roux A, Zielen S.
    Dtsch Med Wochenschr; 2005 Mar 04; 130(9):461-5. PubMed ID: 15731959
    [Abstract] [Full Text] [Related]

  • 44. Vaccinate your child and save its grandparents from a heart attack? Current perspectives in antipneumococcal vaccination.
    Vila-Córcoles A.
    J Intern Med; 2009 Nov 04; 266(5):432-44. PubMed ID: 19754854
    [Abstract] [Full Text] [Related]

  • 45. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
    Reinert RR.
    Laryngorhinootologie; 2006 Apr 04; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
    [Abstract] [Full Text] [Related]

  • 46. Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults.
    Benin AL, O'Brien KL, Watt JP, Reid R, Zell ER, Katz S, Donaldson C, Parkinson A, Schuchat A, Santosham M, Whitney CG.
    J Infect Dis; 2003 Jul 01; 188(1):81-9. PubMed ID: 12825175
    [Abstract] [Full Text] [Related]

  • 47. Education does pay off: pneumococcal vaccine screening and administration in hospitalized adult patients with pneumonia.
    Kruspe R, Lillis R, Daberkow DW, Blais CM, Wilbright W, Gupta S, Gould CA, Sun T, Martinez JA, deBoisblanc B, Ladabaum U, Sanders CV, Lopez FA.
    J La State Med Soc; 2003 Jul 01; 155(6):325-31. PubMed ID: 14750752
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Clinical inquiries. Should patients receive 23-valent pneumococcal vaccination more than once?
    Whiteside J, Grover M, Hitchcock K, Kim R.
    J Fam Pract; 2006 Sep 01; 55(9):809-12. PubMed ID: 16948967
    [Abstract] [Full Text] [Related]

  • 50. [Reply: Position of the Advisory Committee on Immunizations, Chilean Infectious Diseases Society].
    Potin M, Cerda J.
    Rev Chilena Infectol; 2016 Dec 01; 33(6):710-711. PubMed ID: 28146202
    [No Abstract] [Full Text] [Related]

  • 51. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
    Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, Santosham M, O'Brien KL.
    Clin Infect Dis; 2008 Oct 15; 47(8):989-96. PubMed ID: 18781875
    [Abstract] [Full Text] [Related]

  • 52. Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.
    Vila-Corcoles A, Ochoa-Gondar O.
    Expert Rev Vaccines; 2012 Feb 15; 11(2):221-36. PubMed ID: 22309670
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia.
    Andrews RM, Counahan ML, Hogg GG, McIntyre PB.
    Vaccine; 2004 Nov 25; 23(2):132-8. PubMed ID: 15531029
    [Abstract] [Full Text] [Related]

  • 57. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Feb 15; 57(6):144-8. PubMed ID: 18272956
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. 23-valent pneumococcal polysaccharide vaccine (PPV23) for the prevention of invasive pneumococcal diseases (IPDs) in the elderly: is it really effective?
    Cadeddu C, De Waure C, Gualano MR, Di Nardo F, Ricciardi W.
    J Prev Med Hyg; 2012 Jun 15; 53(2):101-3. PubMed ID: 23240169
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.